Fusidic acid and clindamycin resistance in community-associated, methicillin-resistant Staphylococcus aureus infections in children of Central Greece
2010

Fusidic acid and clindamycin resistance in MRSA infections in children

Sample size: 309 publication Evidence: high

Author Information

Author(s): Katopodis George D, Grivea Ioanna N, Tsantsaridou Angeliki J, Pournaras Spyros, Petinaki Efi, Syrogiannopoulos George A

Primary Institution: University of Thessaly, Medical School

Hypothesis

The study aims to evaluate the clinical manifestations and changes in the phenotype and genotype of MRSA isolates in children with community-associated staphylococcal infections.

Conclusion

Fusidic acid and clindamycin should be used cautiously as empiric therapy in areas with high rates of infections caused by multidrug-resistant CA-MRSA isolates.

Supporting Evidence

  • Of 309 children, 180 had infections due to MRSA isolates.
  • 88.9% of CA-MRSA isolates were resistant to fusidic acid.
  • Clindamycin resistance increased from 0% in 2003 to 31.2% in 2009 among CA-MRSA isolates.
  • Multidrug-resistant CA-MRSA isolates increased significantly over the study period.

Takeaway

Doctors found that many children in Greece have infections from a type of bacteria that is hard to treat, and some common medicines don't work well anymore.

Methodology

The study reviewed medical records of children with community-associated staphylococcal infections from January 2003 to December 2009.

Limitations

The study was retrospective and lacked detailed information on maternal infection history and other family members.

Participant Demographics

Children aged 0-14 years with community-associated staphylococcal infections.

Statistical Information

P-Value

P = 0.037

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2334-10-351

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication